Thus, CLL cells are more addicted to the protective activity of Bcl-2 anti-apoptotic members compared to normal cells, and are therefore more sensitive to agents that lower anti-apoptotic protein expression and trigger the consequent massive release of pro-death BH3-only proteins30. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.